A phase 2, 16-week, open-label study in 18 subjects ranging from 6 to 40 years of age results in a mean BMI reduction of 18% in those younger than 18 years, and 6% for those 18 years or older, accompanied by significant reduction of hunger scores ( Figure 4 depicts outcomes for therapies in special populations, such as those with genetic obesity, Prader-Willi Syndrome (PWS), and HO
No medication was mentioned
10.1016/j.peptides.2017.09.018 56
Variants in pharmacokinetic transporters and glycemic response to metformin: a metgen meta-analysis
Side effects are limited appetite and sleep (especially the first couple of days after the shot), nausea (especially when brushing teeth or smelling things), and hair loss (started more around month 6)
Nh my sn xut: E-Pharma Trento S.P.A, via Provina 2 38123 Trento (TN) Italy